SNP | Genotype | Location/functional effect | Healthy subjects | HIV/AIDS patients | Global p-value |
---|---|---|---|---|---|
n (freq) | n (freq) | ||||
NR1I2 rs3732356T>G | T/T | Intron 3 | 95 (0.605) | 162 (0.549) | 0.031 |
T/G | Â | 50 (0.318) | 123 (0.417) | Â | |
G/G | Â | 12 (0.076) | 10 (0.034) | Â | |
NR1I2 rs2472677C>T | C/C | Intron 1, Disrupts HNF3B TFB site | 57 (0.368) | 97 (0.365) | 0.917 |
C/T | 75 (0.484) | 133 (0.500) | Â | ||
T/T | 23 (0.148) | 36 (0.135) | Â | ||
NR1I2 rs6785049G>A | G/G | Intron 5 | 128 (0.853) | 264 (0.950) | 0.002 |
G/A | 21 (0.140) | 14 (0.050) | Â | ||
A/A | 1 (0.007) | 0 (0.000) | Â | ||
NR1I3 rs2307424C>T | C/C | Exon 5, Pro180Pro | 138 (0.879) | 270 (0.915) | 0.216 |
C/T | 19 (0.121) | 25 (0.085) | Â | ||
NR1I3 rs3003596T>C | T/T | Intron 3 | 51 (0.325) | 100 (0.341) | 0.659 |
T/C | 72 (0.459) | 140 (0.478) | Â | ||
C/C | 34 (0.217) | 53 (0.181) | Â | ||
NR1I3 rs2502815C>T | C/C | Intron 3 | 88 (0.564) | 180 (0.610) | 0.173 |
C/T | 53 (0.340) | 100 (0.339) | Â | ||
T/T | 15 (0.096) | 15 (0.051) | Â |